| Balance Sheets | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 355,672 | 294,173 | 287,512 | 49,519 |
| Accounts receivable, net | 628,280 | 638,127 | 680,676 | 574,642 |
| Other receivables | 66,428 | 51,645 | 61,025 | 49,325 |
| Prepaid expenses and other current assets | 76,369 | 93,276 | 52,191 | 61,293 |
| Total current assets | 1,126,749 | 1,077,221 | 1,081,404 | 734,779 |
| Property and equipment, net | 1,133,849 | 1,032,474 | 998,541 | 924,833 |
| Operating lease right-of-use assets | 3,000,426 | 3,034,828 | 3,075,507 | 2,557,026 |
| Insurance subsidiary deposits and investments | 80,300 | 79,159 | 67,910 | 47,200 |
| Escrow funds | 24,418 | 23,406 | 21,810 | 23,584 |
| Goodwill and other indefinite-lived assets | 68,061 | 67,061 | 67,061 | 65,291 |
| Other assets | 193,089 | 188,020 | 182,167 | 164,003 |
| Total assets | 5,626,892 | 5,502,169 | 5,494,400 | 4,516,716 |
| Accounts payable | 205,479 | 172,023 | 198,617 | 154,744 |
| Accrued payroll and benefits | 252,539 | 193,034 | 210,215 | 155,390 |
| Current operating lease liabilities | 150,651 | 145,041 | 141,620 | 131,025 |
| Current maturities of long-term debt | 7,474 | 10,146 | 12,959 | 15,806 |
| Current portion of accrued self-insurance liabilities | 120,914 | 83,453 | 75,464 | 34,104 |
| Line of credit | 100,000 | 142,000 | 142,000 | - |
| Refund liability | 181,133 | 173,595 | 162,154 | 83,987 |
| Other accrued expenses | 179,431 | 247,939 | 164,384 | 106,666 |
| Total current liabilities | 1,197,621 | 1,167,231 | 1,107,413 | 681,722 |
| Long-term operating lease liabilities | 2,962,999 | 2,991,408 | 3,024,140 | 2,491,684 |
| Lines of credit | - | - | - | 0 |
| Long-term debt, less current maturities, net of deferred financing fees | 245,903 | 246,992 | 249,089 | 253,645 |
| Accrued self-insurance liabilities, less current portion | 177,480 | 207,635 | 186,705 | 188,192 |
| Other liabilities | 165,973 | 76,235 | 170,780 | 234,729 |
| Total liabilities | 4,749,976 | 4,689,501 | 4,738,127 | 3,849,972 |
| Common stock 0.001 par value 1,250,000,000 shares authorized 156,615,144 shares issued and outstanding as of september30, 2025, and 155,177,511 shares issued and outstanding as of december31, 2024 | 157 | 157 | 155 | 155 |
| Additional paid-in capital | 621,288 | 609,212 | 603,565 | 579,058 |
| Retained earnings | 249,877 | 197,471 | 146,508 | 80,835 |
| Total stockholders' equity | 871,322 | 806,840 | 750,228 | 660,048 |
| Noncontrolling interest in subsidiary | 5,594 | 5,828 | 6,045 | 6,696 |
| Total equity | 876,916 | 812,668 | 756,273 | 666,744 |
| Total liabilities and equity | 5,626,892 | 5,502,169 | 5,494,400 | 4,516,716 |
PACS Group, Inc. (PACS)
PACS Group, Inc. (PACS)